Research progress on clinical efficacy of postoperative radiotherapy for resectable pathological stage Ⅲ A-N 2 non-small cell lung cancer
10.3760/cma.j.cn113030-20190509-00171
- VernacularTitle:ⅢA-N2期非小细胞肺癌根治术后放疗疗效影响因素的研究进展
- Author:
Cuimeng TIAN
1
;
Baolan LI
Author Information
1. 首都医科大学附属北京胸科医院放疗科 101149
- From:
Chinese Journal of Radiation Oncology
2020;29(10):909-912
- CountryChina
- Language:Chinese
-
Abstract:
With the development of modern radiotherapy technology, the significance of postoperative radiotherapy in treating resectable stage Ⅲ A-N 2 non-small cell lung cancer has been emphasized. At present, the value of postoperative radiotherapy has been controversial due to the lack of large-size prospective randomized controlled studies. A large number of retrospective studies have confirmed that the efficacy of postoperative radiotherapy is significantly correlated with different clinicopathological characteristics. In this article, the influencing factors of the efficacy of postoperative radiotherapy were analyzed, and the subgroup of patients receiving clinical benefits was discussed, aiming to achieve precise postoperative radiotherapy.
